1. |
Jonas RA, 主編. 先天性心臟病外科綜合治療學. 北京:北京大學醫學出版社, 2009. 286.
|
2. |
Oechslin EN, Harrison DA, Harris L, et al. Reoperation in adults with repair of tetralogy of Fallot: indications and outcomes. J Thorac Cardiovasc Surg, 1999, 118 (2):245-251.
|
3. |
Roos-Hesselink J, Perlroth MG, McGhie J, et al. Atrial arrhyth-mias in adults after repair of tetralogy of Fallot. Correlations with clinical, exercise, and echocardiographic ?ndings. Circulation, 1995, 91 (8):2118-2119.
|
4. |
Niezen RA,Helbing WA,van der Wall EE,et al.Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy of Fallot. Radiology, 1996, 201 (1):135-140.
|
5. |
Eyskens B, Reybrouck T, Bogaert J, et al. Homograft insertion for pulmonary regurgitation after repair of tetralogy of Fallot improves cardiorespiratory exercise performance. Am J Cardiol, 2000, 85(2):221-225.
|
6. |
Gatzoulis MA, Balaji S,Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet, 2000, 356 (9234):975-981.
|
7. |
Lu WD, Zhang M, Wu ZS, et al. The performance of photooxidatively crosslinked acellular bovine jugular vein conduits in the reconstruction of connections between pulmonary arteriesand right ventricles. Biomaterials, 2010, 31 (10):2934-2943.
|
8. |
Ross DN. Homograft replacement of the aortic valve. Lancet, 1962,2 (7254):487.
|
9. |
Askovich B, Hawkins JA, Sower CT, et al. Right ventricle-to-pulmonary artery conduit longevity: is it related to allograft size? Ann Thorac Surg, 2007, 84 (3):907-911.
|
10. |
Elkins RC, Knott-Craig CJ, Ward EW, et al. The Ross operation in children: 10-year experience. Ann Thorac Surg, 1998, 65 (2):496-502.
|
11. |
Wells WJ, Arroyo H, Bremner RM, et al. Homograft conduit failure in infants is not due to somatic outgrowth. J Thorac Cardiovasc Surg, 2002, 124 (1):88-96.
|
12. |
Schorn K, Yankah AC, Alexi-Meskhishvilli VA, et al. Risk factors for early degeneration of allografts in pulmonary circulation. Eur J Cardiothorac Surg, 1997, 11 (1):62-69.
|
13. |
Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation, 2000, 102 (19):suppl III130-133.
|
14. |
Forbess JM, Shah AS, St Louis JD, et al. Cryopreserved homografts in the pulmonary position:determinants of durability. Ann Thorac Surg, 2001, 71 (1):54-60.
|
15. |
Herijgers P, Ozaki S, Verbeken E, et al. Valved jugular vein segments for right ventricular outflow tract reconstruction in young sheep. J Thorac Cardiovasc Surg, 2002, 124 (4):798-805.
|
16. |
Ichikawa Y, Noishiki Y, Yamamoto K, et al. Use of bovine jugular vein graft with natural valve for right ventricular outflow tract reconstruction: a one-year animal study. J Thorac Cardiovasc Surg, 1997, 114 (2):224-233.
|
17. |
徐朝軍, 宋嵐, 吳忠仕, 等. 環氧交聯去細胞牛頸靜脈帶瓣管道的血液相容性實驗研究. 中國胸心血管外科臨床雜志, 2011, 18 (4):338-342.
|
18. |
Fiore AC, Brown JW, Turrentine WT, et al. A bovine jugular vein conduit: a ten-year bi-institutional experience. Ann Thorac Surg, 2011, 92 (1):183-192.
|
19. |
Natasha Prior, Nelson Alphonso, Philip Arnold, et al. Bovine jugular vein valved conduit: Up to 10 years follow-up. J Thorac Cardiovasc Surg, 2011, 141 (4):983-987.
|
20. |
Andrew C, Mark Ruzmetov, Danny Huynh, et al. Comparison of bovine jugular vein with pulmonary homograft conduits in children less than 2 years of age. Eur J Cardiothorac Surg, 2010, 38 (3):318-325.
|
21. |
Breymann T, Blanz U, Wojtalik MA, et al. European Contegra multicentre study: 7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovasc Surg, 2009, 57 (5):257-269.
|
22. |
Niclauss L, Delay D, Hurni M, et al. Experience and intermediate-term results using the Contegra heterograft for right ventricular outflow reconstruction in adults. Interact Cardiovasc Thorac Surg, 2009, 9 (4): 667-671.
|
23. |
Palma G, Mannacio VA, Mastrogiovanni G, et al. Bovine valved venous xenograft in pulmonary position: medium term evaluation of risk factors for dysfunction and failure after 156 implants. J Cardiovasc Surg (Torino), 2011, 52 (2):285-291.
|
24. |
Breymann T, Thies WR, Boethig D, et al. Bovine valved venous xenografts for RVOT reconstruction:results after 71 implantations. Eur J Cardiothorac Surg, 2002, 21 (4):703-710.
|
25. |
Tiete AR, Sachweh JS, Roemer U, et al. Right ventricular out?ow tract reconstruction with the Contegra jugular vein conduit: a word of caution. Ann Thorac Surg, 2004, 77 (6):2151-2156.
|
26. |
Meyns B, Van Garsse L, Boshoff D, et al. The Contegra conduit in the right ventricular outflow tract induced supravalvular stenosis. J Thorac Cardiovasc Surg, 2004, 128 (6):834-840.
|
27. |
Rastan AJ, Walther T, Daehnert I, et al. Bovine jugular vein conduit for righ ventricularoutflow tract reconstruction: evaluation of risk factors for mid-term outcome. Ann Thorac Surg, 2006, 82 (4):1308-1315.
|
28. |
Sekarski N, van Meir H, Rijlaarsdam ME, et al. Right ventricular outflow tract reconstruction with the bovine jugular vein graft: 5 years’ experience with 133 Patients. Ann Thorac Surg, 2007, 84 (2):599-605.
|
29. |
Bajraktari G,Olloni R,Daullxhiu I,et al.MRSA endocarditis of bovine contegra valved conduit: a case report. Cases J,2009,2 (1):57.
|
30. |
Christenson JT, Sierra J, Colina Manzano NE, et al. Homografts and xenografts for right ventricular outflow tract reconstruction: long-term results. Ann Thorac Surg, 2010, 90 (4):1287-1293.
|